{"id":138167,"date":"2022-04-15T14:02:30","date_gmt":"2022-04-15T19:02:30","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/04\/youthbio-therapeutics-new-epigenetic-rejuvenation-startup-emerges-from-stealth"},"modified":"2022-04-15T14:02:30","modified_gmt":"2022-04-15T19:02:30","slug":"youthbio-therapeutics-new-epigenetic-rejuvenation-startup-emerges-from-stealth","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/04\/youthbio-therapeutics-new-epigenetic-rejuvenation-startup-emerges-from-stealth","title":{"rendered":"YouthBio Therapeutics: New Epigenetic Rejuvenation Startup Emerges from Stealth"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/youthbio-therapeutics-new-epigenetic-rejuvenation-startup-emerges-from-stealth3.jpg\"><\/a><\/p>\n<p>Seattle-based longevity biotech YouthBio Therapeutics has emerged from stealth mode, revealing it is working on the development of \u201cgene therapies aimed at epigenetic rejuvenation, particularly with the help of partial reprogramming by Yamanaka factors.\u201d The company boasts some top longevity science talent, with Dr Jo\u00e3o Pedro de Magalh\u00e3es serving as its chief scientific officer and Dr Alejandro Ocampo as lead research collaborator.<\/p>\n<p><strong><em>Longevity. Technology: Cellular reprogramming is hot, hot hot! <a href=\"https:\/\/youthbiotx.com\/\" target=\"_blank\" rel=\"noopener\">YouthBio<\/a> joins a growing list of companies, including <a href=\"https:\/\/www.longevity.technology\/altos-labs-lands-3-billion-to-further-cellular-rejuvenation-programming\/\" target=\"_blank\" rel=\"noopener\">Altos Labs<\/a>, <a href=\"https:\/\/www.longevity.technology\/shifting-gear-startup-aims-to-de-risk-rejuvenation-therapy\/\" target=\"_blank\" rel=\"noopener\">Shift Bioscience<\/a> and <a href=\"https:\/\/www.longevity.technology\/turn-bio-announce-worldwide-ip-for-mrna-tech\/\" target=\"_blank\" rel=\"noopener\">Turn Bio<\/a>, among others, all aiming to change the course of human health through this exciting, yet early stage, science. Like everyone else, we\u2019ll be watching all the players very closely \u2013 where will the first major breakthrough come from? <\/em><\/strong><\/p>\n<p>Cellular reprogramming is the process by which aged cells can be returned to a pluripotent (embryonic-like) state. This process, which can be achieved using <a href=\"https:\/\/www.longevity.technology\/yamanaka-factors\/\" target=\"_blank\" rel=\"noopener\">Yamanaka factors<\/a>, also improves the cells\u2019 aging hallmarks. Partial reprogramming means that Yamanaka factors are induced only for short periods, which is not enough to fully change cells beyond a point of no return but is enough to induce rejuvenation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Seattle-based longevity biotech YouthBio Therapeutics has emerged from stealth mode, revealing it is working on the development of \u201cgene therapies aimed at epigenetic rejuvenation, particularly with the help of partial reprogramming by Yamanaka factors.\u201d The company boasts some top longevity science talent, with Dr Jo\u00e3o Pedro de Magalh\u00e3es serving as its chief scientific officer and [\u2026]<\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,269],"tags":[],"class_list":["post-138167","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/138167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=138167"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/138167\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=138167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=138167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=138167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}